doi: 10.3389/fonc.2026.1751474 Received 21 November 2025 Revised 14 January 2026 Accepted 03 February 2026 Published 18 February 2026 Volume 16 - 2026 Edited by Dana Kristjansson, Norwegian Institute of Public Health (NIPH), Norway Reviewed by Feng Wang, Affiliated Hospital of Nantong University, China Bingran Yu, Shandong University, China Updates Copyright 2026 Pathania and Osna
However, there are no relevant research reports on the mechanism of action of GPX6, which may be related to the oxidative stress response involved in glutathione
Drug-induced acute kidney injury: Epidemiology, mechanisms, risk factors, and preventive treatment of traditional Chinese medicine
A pro-angiogenic effect of PCSK9 inhibition may be a drawback of using PCSK9 inhibitors in cancer and necessitate its combination with other therapies such as anti-angiogenic agents in this setting
The gold standard supplement for athletes and bodybuilders
If your pharmacy or supplier offers a choice, go with 31G for the best comfort
